These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 36186835)
1. Clinical and autoantibody phenotypes of juvenile dermatomyositis. Boyarchuk O; Kuka A; Yuryk I Reumatologia; 2022; 60(4):281-291. PubMed ID: 36186835 [TBL] [Abstract][Full Text] [Related]
2. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW; Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355 [TBL] [Abstract][Full Text] [Related]
3. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Shah M; Mamyrova G; Targoff IN; Huber AM; Malley JD; Rice MM; Miller FW; Rider LG; Medicine (Baltimore); 2013 Jan; 92(1):25-41. PubMed ID: 23263716 [TBL] [Abstract][Full Text] [Related]
4. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis. He L Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1064-1068. PubMed ID: 34719424 [TBL] [Abstract][Full Text] [Related]
5. Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies. Perron MM; Vasquez-Canizares N; Tarshish G; Wahezi DM Pediatr Rheumatol Online J; 2021 Jun; 19(1):92. PubMed ID: 34118936 [TBL] [Abstract][Full Text] [Related]
6. Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis. Karasawa R; Yudoh K; Sato T; Tanaka M; Tamaki M; Sabbagh SE; O'Hanlon TP; Noroozi-Farhadi P; Targoff IN; Flegel WA; Mammen AL; Miller FW; Hicar MD; Rider LG; Jarvis JN Rheumatology (Oxford); 2022 Jul; 61(7):2969-2977. PubMed ID: 34791087 [TBL] [Abstract][Full Text] [Related]
7. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature. Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969 [TBL] [Abstract][Full Text] [Related]
9. Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes. Kim H; Huber AM; Kim S Rheum Dis Clin North Am; 2021 Nov; 47(4):669-690. PubMed ID: 34635298 [TBL] [Abstract][Full Text] [Related]
10. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203 [TBL] [Abstract][Full Text] [Related]
11. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies. Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809 [TBL] [Abstract][Full Text] [Related]
12. Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis. Soponkanaporn S; Deakin CT; Schutz PW; Marshall LR; Yasin SA; Johnson CM; Sag E; Tansley SL; McHugh NJ; Wedderburn LR; Jacques TS Neuropathol Appl Neurobiol; 2019 Jun; 45(4):410-420. PubMed ID: 29770465 [TBL] [Abstract][Full Text] [Related]
13. Autoantibody Profile of Children with Juvenile Dermatomyositis. Sharma A; Bhattarai D; Gupta A; Guleria S; Rawat A; Vignesh P; Garg R; Singh S Indian J Pediatr; 2021 Dec; 88(12):1170-1173. PubMed ID: 33694062 [TBL] [Abstract][Full Text] [Related]
15. Angioedema-like presentation as the presenting finding of juvenile myositis and juvenile dermatomyositis in 2 patients. Karaca Ö; Güngör M; Sakarya Güneş A; Eser Şimşek I; Anık Y; Kara B Int J Rheum Dis; 2022 May; 25(5):617-625. PubMed ID: 35238477 [TBL] [Abstract][Full Text] [Related]
16. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. Rider LG; Nistala K J Intern Med; 2016 Jul; 280(1):24-38. PubMed ID: 27028907 [TBL] [Abstract][Full Text] [Related]
17. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. Wu JQ; Lu MP; Reed AM World J Pediatr; 2020 Feb; 16(1):31-43. PubMed ID: 31556011 [TBL] [Abstract][Full Text] [Related]